Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial Meeting Abstract


Authors: George, S.; Motzer, R. J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S. S.; Plimack, E.; Jiang, J.; Waxman, I.; Rini, B. I.
Abstract Title: Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S102
End Page: S103
Language: English
ACCESSION: WOS:000361887400311
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)30303-3
Notes: Meeting Abstract: 501 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer